All PharmaTec Content

Bringing you the latest research in digitalisation, automation and data handling through a range of Speaker Interviews, Industry Insights, and Expert Opinions.

Discussion Group Report
Our April 2022 discussion group focused on digital therapeutics. Digital therapeutics are software-based products for the prevention, management and treatment of health conditions.
Edited by Oliver Picken |
14 June 2022
Pharma Data
Commentary
Jackie Hunter, Board Director at BenevolentAI, shares details on her company's unique approach to target Identification and lead optimisation.
Edited by Oliver Picken |
07 June 2022
AI & Machine Learning
Insight Article
Data is one of the most important assets for a company but multi-omics data analysis is a challenging field.
Edited by Oliver Picken |
27 May 2022
Pharma Data
Insight Article
The pharma industry is embracing digitalisation of the lab. Recent advancements in paperless technology and AI offer a peak into what the smart labs of the future will look like.
Edited by Oliver Picken |
24 May 2022
SmartLabs
Discussion Group Report
Digital health is often seen as the 'next big thing' but there are challenges ahead. This month, our discussion group focused on fragmentation, data flow, protection and regulatory approval.
Edited by Oliver Picken |
05 May 2022
Pharma Data
Commentary
This Commentary article revisits the development and implementation of mobile health data, exploring how initiatives such as the NHS track and trace system helped to mitigate the worst of the impact of the Covid-19 pandemic. Here, we consider the applications of mHealth data for present and future pandemic situations.
Edited by Ben Norris |
26 April 2022
Pharma Data
Insight Article
Digital biomarkers are rapidly being adopted to provide quality insights into patient health. David Nobbs, Biomarker Disease Area Lead at Roche and Valentin, Data Analytics Leader at GSK share how their companies are using digital biomarkers.
Edited by Oliver Picken |
25 April 2022
Pharma Data
Commentary
This Commentary piece looks at the means by which the global approval process for new medicines can be sped up through the controlled use of FAIR data. Key areas of focus include the sharing of healthcare data to bring the patient voice within the clinical setting.
Edited by Ben Norris |
28 March 2022
Pharma Data
Discussion Group Report
Key opinion leaders discuss the latest trends and challenges in laboratory automation and digitalization. Key insights include an explanation of Roche's 'Levers of Production' method, the challenges of legacy systems and the possibility of digitalization overload.
Edited by Oliver Picken |
21 March 2022
SmartLabs
Insight Article
The pharmaceutical industry is working on improving the usability of automation platforms but challenges remain.
Edited by Oliver Picken |
10 March 2022
SmartLabs

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login